ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,693Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 337

$524K Total Retail Price of All Prescriptions

Rank: 65 out of 337

485 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 11,385 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 903 833 1 2
SIMVASTATIN 792 715 2 1
AMLODIPINE BESYLATE 764 727 3 3
HYDROCHLOROTHIAZIDE 665 599 4 9
ATORVASTATIN CALCIUM 581 554 5 7
LOVASTATIN 457 414 6 24
OMEPRAZOLE 430 380 7 4
METFORMIN HCL 418 358 8 12
LEVOTHYROXINE SODIUM 396 360 9 5
ATENOLOL 364 344 10 10
METOPROLOL TARTRATE 303 263 11 6
CITALOPRAM HBR 232 199 12 17
ALENDRONATE SODIUM 226 222 13 19
WARFARIN SODIUM 225 224 14 11
CRESTOR 216 187 15 29
ATENOLOL-CHLORTHALIDONE 208 196 16 148
FUROSEMIDE 206 202 17 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 181 18 31
GLIMEPIRIDE 158 134 19 55
FENOFIBRATE 153 133 20 48
FLUOXETINE HCL 135 135 21 57
LOSARTAN POTASSIUM 134 127 22 15
HYDROCODONE-ACETAMINOPHEN 113 92 S3 23 13
KLOR-CON M20 106 97 24 65
AMITRIPTYLINE HCL 101 101 R 25 75
INSULIN SYRINGE 98 89 26 127
METOPROLOL SUCCINATE 97 97 27 21
METFORMIN HCL ER 93 88 28 52
ALPRAZOLAM 80 79 29 78
DIOVAN 80 77 29 26
NOVOLOG MIX 70-30 FLEXPEN 77 63 31 219
ALLOPURINOL 77 65 31 28
NAPROXEN 75 48 33 98
QUINAPRIL HCL 72 59 34 50
PROAIR HFA 70 51 35 38
PANTOPRAZOLE SODIUM 69 60 36 36
LANTUS 68 58 37 49
LIPITOR 67 67 38 33
PEN NEEDLE 66 55 39 236
ZOLPIDEM TARTRATE 61 57 40 23
TRAMADOL HCL 57 47 41 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 56 41 139
GLIPIZIDE ER 54 51 43 69
VERAPAMIL ER 53 46 44 77
PREDNISONE 51 48 45 40
HUMALOG MIX 75-25 50 44 46 319
PRAVASTATIN SODIUM 50 40 46 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.